Home-based telerehabilitation for rural men on hormone therapy for metastatic prostate cancer
Impact of Multimodal Telerehabilitation on Reducing Disparities in Rural Survivors of Metastatic Prostate Cancer
This trial tests whether a home telerehabilitation program helps men in rural areas receiving androgen deprivation therapy for metastatic prostate cancer feel and function better than home exercise without the technology.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 74 (estimated) |
| Ages | 21 Years and up |
| Sex | Male |
| Sponsor | University of Utah Academic / other |
| Locations | 1 site (Salt Lake City, Utah) |
| Trial ID | NCT07032584 on ClinicalTrials.gov |
What this trial studies
This randomized interventional study will enroll men with prostate cancer on androgen deprivation therapy who live in rural areas, randomizing them to multimodal telerehabilitation delivered at home versus home exercise without the telehealth technology. The intervention uses remote supervision and digital tools to guide exercise and rehabilitation, with participants followed for six months. The team will compare quality of life and cancer-related symptoms between groups and assess feasibility and acceptance of the program. Enrollment and oversight are coordinated through the Huntsman Cancer Institute at the University of Utah.
Who should consider this trial
Good fit: Men aged 21 or older with confirmed prostate cancer who are receiving standard-of-care androgen deprivation therapy and who reside in rural communities (RUCA code ≥4) are ideal candidates.
Not a fit: Patients with unstable cardiac disease, painful or unstable bony metastases, recent fractures, those already in a formal exercise rehabilitation program, or those planning to relocate within six months are unlikely to benefit or be eligible.
Why it matters
Potential benefit: If successful, this approach could give rural patients supervised, convenient rehabilitation at home that reduces treatment side effects and improves quality of life without frequent travel.
How similar studies have performed: Prior pilot studies and trials in other cancer and older adult populations have shown high acceptance and clinical benefit of home-based telerehabilitation, but multimodal telerehabilitation specifically for rural patients with metastatic prostate cancer has not been systematically tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age 21 years or older 2. Confirmed diagnosis of prostate cancer 3. Men receiving standard-of-care ADT either for high-risk, locally advanced prostate cancer or as a part of multicomponent management of metastatic prostate cancer; 4. Residing in a rural community defined by the Rural-Urban Commuting Area (RUCA) codes from the Federal Office of Rural Health Policy (4 and higher). Exclusion Criteria: 1. Have unstable angina, uncontrolled hypertension, recent myocardial infarction, pacemakers, painful or unstable bony metastases, or recent skeletal fractures. 2. Are engaged in a regular exercise rehabilitation program. 3. Have relocation plans within the next 6 months 4. Participate in another clinical trial related to prostate cancer or rehabilitation. The patients will also be required to have a working telephone line in their home or a cell phone.
Where this trial is running
Salt Lake City, Utah
- University of Utah Huntsman Cancer Institute — Salt Lake City, Utah, United States (Recruiting)
Study contacts
- Principal investigator: Manish Kohli, MD — University of Utah
- Study coordinator: Manish Kohli, MD
- Email: Manish.Kohli@hci.utah.edu
- Phone: 801-646-4018
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.